The endocrine pancreas, obesity, and diffuse endocrine and chemical mediators

Physiological Basis of Aging and Geriatrics, Fourth Edition

Volumn , Issue , 2007, Pages 219-230

  Timiras, Paola S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84555201430     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Quay WB. Regulation of nutrient metabolism. In: Timiras PS, Quay WB, Vernadakis A, eds. Hormones and Aging. Boca Raton: CRC Press, 1995: 169-200.
2. Ghosh K, Sinclair AJ. Diabetes in older people. Practitioner 2005; 249(1675): 702-707.
3. Sowers JR. Diabetes in the elderly and in women: cardiovascular risks. Cardiol Clin 2004; 22(4): 541-551.
4. Sorkin JD, Muller DC, Fleg JL, et al. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 2005; 28(11): 2626-2632.
5. Sugawara K, Kobayashi T, Nakanishi K, et al. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas. Pancreas 1993; 8(3): 312-315.
6. Reaven E, Wright D, Mondon CE, et al. Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes 1993; 32(2): 175-180.
7. Chaudhuri M, Sartin JL, Adelman RC. A role for somatostatin in the impaired insulin secretory response to glucose by islets from aging rats. J Gerontol 1983; 38(4): 431-435.
8. Maddux BA, Chang YN, Accili D, et al. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab 2006; 290(4): E746-E749.
9. Wente SR, Rosen OM. Insulin-receptor approaches to studying protein kinase domain. Diabetes Care 1990; 13(3): 280-287.
10. Alper J. Biomedicine: new insights in type 2 diabetes. Science 2000; 289(5476): 37-39.
11. Withers DJ, White M. Perspective: the insulin signaling system: a common link in the pathogenesis of type 2 diabetes. Endocrinology 2000; 141(6): 1917-1921.
12. Kido Y, Burks DJ, Withers D, et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Investig 2000; 105(2): 199-205.
13. Zhang J, Hupfeld, CJ, Taylor SS, et al. Insulin disrupts betaadrenergic signaling to protein kinase A in adipocytes. Nature 2005; 437(7058): 569-573.
14. Hsia SH, Davidson MB. Established therapies for diabetes mellitus. Curr Med Res Opin 2002; 18(suppl 1): s13-s21.
15. Hampson LJ, Agius L. Increased potency and efficacy of combined phosphorylase inactivation and glucokinase activation in control of hepatocyte glycogen metabolism. Diabetes 2005; 54(3): 617-623.
16. Lindberg O, Tilvis RS, Strandberg TE. Does fasting plasma insulin increase by age in the general elderly population? Aging 1997; 9(4): 277-280.
17. Garcia GV, Freeman RV, Supiano, et al. Glucose metabolism in older adults: a study including subjects more than 80 years of age. J Am Geriatr Soc 1997; 45(7): 813-817.
18. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21(4): 518-524.
19. Halter JB. Diabetes mellitus in older adults: underdiagnosis and undertreatment. Am J Geriatr Soc 2000; 48(3): 340-341.
20. Simonson DC, DeFronzo RA. Glucagon physiology and aging: evidence for enhanced hepatic sensitivity. Diabetologia 1983; 25(1): 1-17.
21. Jackson RA. Mechanisms of age-related glucose intolerance. Diabetes Care 1990; 13(suppl 2): 9-19.
22. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005; 47(4): 201-210.
23. LeRoith D. Insulin-like growth factors. N Engl J Med 1997; 336(9): 633-640.
24. Polonsky KS, Sturis J, Bell GI. Non-insulin dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996; 334(12): 777-783.
25. Fink RI, Kolterman OG, Kao M, et al. The role of the glucose transport system in the postreceptor defect in insulin action associated with human aging. J Clin Endocrinol Metab 1984; 58(4): 721-725.
26. Gold G, Reaven GM, Reaven EP. Effect of age on pro-insulin and insulin secretory patterns in isolated rat islets. Diabetes 1981; 30(1): 77-82.
27. O’Rahilly S, Gray H, Humphreys PJ, et al. Brief report: impaired processing of hormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med 1995; 333(21): 1386-1390.
28. Olefsky JM, Reaven GM. Effects of age and obesity on insulin binding adipocytes. Endocrinology 1975; 96(6): 1486-1498.
29. Finucane P, Popplewell P. Diabetes Mellitus and impaired glucose regulation in old age: the scale of the problem. In: Sinclair AJ, Finucane P, eds. Diabetes in Old Age. 2nd ed. New York: John Wiley & Sons, 2001: 3-16.
30. Knowler WC, Bennett PH, Hamman RF, et al. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108(6): 497-505.
31. American Diabetes Association: Clinical Pract ice Recommendations 1998. An up-to-date summary of the current classifications of diabetes and standards of care for the management of diabetic care of patients, including the goals of treatment. Diabetes Care 1998; 21(suppl 1).
32. Morley JE, Kaiser FE. Unique aspects of diabetes mellitus in the elderly. Clin Geriatr Med 1990; 6(4): 693-702.
33. Singh I, Marshall MC. Diabetes mellitus in the elderly. Endocrinol Metab Clin North Am 1995; 24(2): 255-272.
34. Dornan TL, Peck GM, Dow JD, et al. A community survey of diabetes in the elderly. Diabetic Med 1992; 9(9): 860-865.
35. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13(5): 513-521.
36. Larsson J, Apelqvist J, Agardh CD, et al. Decreasing incidence of major amputation in diabetic patients: a consequence of multidisciplinary foot care team approach? Diabetic Med 1995; 12(9): 770-776.
37. Damsgaard EM, Froland A, Green A. Use of hospital services by elderly diabetics and fasting hyperglycemic patients aged 60-74 years. Diabetic Med 1987; 4(4): 317-321.
38. Kannell WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. J Am Med Assoc 1979; 241(19): 2035-2038.
39. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with or without prior myocardial infarction. N Engl J Med 1998; 339(4): 229-234.
40. Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic and prediabetic patients. J Clin Invest 1968; 47(9): 1973-1999.
41. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 1987; 3(2): 463-524.
42. Cerami A, Vlassara H, Brownlee M. Glucose and aging. Sci Amer 1987; 256(5): 90-96.
43. Cerami A, Vlassara H, Brownlee M. Role of advanced glycosylation products in complications of diabetes. Diabetes Care 1988; 11(suppl 1): 73-79.
44. Goldstein S. Human genetic disorders that feature premature onset and accelerated progression of biological aging. In: Schneider EL, ed. The Genetics of Aging. New York: Plenum Press, 1978: 171-224.
45. Grimble RF. Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care 2003; 6(1): 21-29.
46. Lechleitner M, Herold M, Dzien-Bischinger C, et al. Tumour necrosis factor-alpha plasma levels in elderly patients with type 2 diabetes mellitus: observations over 2 years. Diabet Med 2002; 19(11): 949-953.
47. Hak AE, Pols HA, Stehouwer CD, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 2001; 86(9): 4398-4405.
48. Tattersall RB, Pyke DA. Diabetes in identical twins. Lancet 1972; 2(7787): 1120-1125.
49. Kennedy RL, Chokkalingham K, Srinivasan R. Obesity in the elderly: who should we be treating, and why, and how? Curr Opin Clin Nutr Metab Care 2004; 7(1): 3-9.
50. Villareal DT, Apovian CM, Kushner RF, et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res 2005; 13(11): 1849-1863.
51. Zamboni M, Mazzali G, Zoico E, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes 2005; 29(9): 1011-1029.
52. Baumgartner RN, Stauber PM, McHugh D, et al. Cross-sectional age differences in body composition in persons 60+ years of age. J Gerontol A Biol Sci Med Sci 1995; 50(6): M307-M316.
53. Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 1997; 83(1): 229-239.
54. http://www.medscape.com/viewarticle/536463 (accessed July 2006).
55. Reaven GM, Laws A. Insulin Resistance, the Metabolic Syndrome X. Totowa: Humana Press, 1999.
56. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83(6): 1237-1247.
57. Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg 2004; 240(2): 243-247.
58. St. Peter SD, Craft RO, Tiede JL, et al. Impact of advanced age on weight loss and health benefits after laparoscopic gastric bypass. Arch Surg 2005; 140(2): 165-168.
59. Sosa JL, Pombo H, Pallavacini H, et al. Laparoscopic gastric bypass beyond age 60. Obes Surg 2004; 14(10): 1398-1401.
60. Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation. Methods Mol Biol 2006; 333: 47-104.
61. Rendell M. Dietary treatment of diabetes mellitus. N Engl J Med 2000; 342(19): 1440-1441.
62. Chandalia M, Garg A, Lutjohann D, et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342(19): 1392-1398.
63. Shorr RI, Franse LV, Resnick HE, et al. Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 2000; 48(3): 264-267.
64. Kitabchi AE, Temprosa M, Knowler WC, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005; 54(8): 2404-2414.
65. Ryan AS, Pratley RE, Goldberg AP, et al. Resistive training increases insulin action in postmenopausal women. J Gerontol 1996; 51(5): M199-M205.
66. Dela F, Mikines KJ, Larsen JJ, et al. Training induced enhancement of insulin action in human skeletal muscle: the influence of aging. J Gerontol 1996; 51(4): B247-B252.
67. Pratley RE, Hagberg JM, Dengel DR, et al. Aerobic exercise training-induced reductions in abdominal fat and glucosestimulated insulin response in middle-aged and older men. J Am Geriatr Soc 2000; 48(9): 1055-1061.
68. Caruso LB, Silliman RA, Demissie S, et al. What can we do to improve physical function in older persons with type 2 diabetes? J Gerontol 2000; 55(7): M372-M377.
69. UK Prospective Diabetes Study Group, Turner RC, et al. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352(9131): 837-853.
70. Sinclair AJ, Turnbull CJ, Croxson SCM. Document of care for older people with diabetes. Postgrad Med J 1996; 72(848): 334-338.
71. McConnell JG, Alam MJ, O’Hare MM, et al. The effect of age and sex on the response of enteropancreatic polypeptides to oral glucose. Age Ageing 1983; 12(1): 54-62.
72. Giugliano D, Giannetti G, DiPinto P, et al. Normalization by sodium salicylate of the impaired counterregulatory glucagon response to hypoglycemia in insulin-dependent diabetes. A possible role for endogenous prostaglandins. Diabetes 1985; 34(6): 521-525.
73. Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis 1993; 21(suppl 3): 32-38.
74. Levy J, Grunberger G, Karl I, et al. Effects of food restriction and insulin treatment on (Ca2++ Mg2+)-ATPase response to insulin in kidney basolateral membranes of non-insulin-dependent diabetic rats. Metabolism 1990; 39(1): 25-33.